Dataset Information


Sedation in gastrointestinal endoscopy: Where are we at in 2014?

ABSTRACT: Gastrointestinal endoscopies are invasive and unpleasant procedures that are increasingly being used worldwide. The importance of high quality procedures (especially in colorectal cancer screening), the increasing patient awareness and the expectation of painless examination, increase the need for procedural sedation. The best single sedation agent for endoscopy is propofol which, due to its' pharmacokinetic/dynamic profile allows for a higher patient satisfaction and procedural quality and lower induction and recovery times, while maintaining the safety of traditional sedation. Propofol is an anesthetic agent when used in higher doses than those needed for endoscopy. Because of this important feature it may lead to cardiovascular and respiratory depression and, ultimately, to cardiac arrest and death. Fueled by this argument, concern over the safety of its administration by personnel without general anesthesia training has arisen. Propofol usage seems to be increasing but it's still underused. It is a safe alternative for simple endoscopic procedures in low risk patients even if administered by non-anesthesiologists. Evidence on propofol safety in complex procedures and high risk patients is less robust and in these cases, the presence of an anesthetist should be considered. We review the existing evidence on the topic and evaluate the regional differences on sedation practices.


PROVIDER: S-EPMC4325306 | BioStudies | 2015-01-01


REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC6126059 | BioStudies
2021-01-01 | S-EPMC7792218 | BioStudies
2020-01-01 | S-EPMC7204791 | BioStudies
2013-01-01 | S-EPMC3540096 | BioStudies
2020-01-01 | S-EPMC7449000 | BioStudies
2020-01-01 | S-EPMC7418437 | BioStudies
2015-01-01 | S-EPMC4315567 | BioStudies
2019-01-01 | S-EPMC6706375 | BioStudies
2018-01-01 | S-EPMC6211481 | BioStudies
2012-01-01 | S-EPMC3332296 | BioStudies